EN
HI
Summary
As of 13 Nov, 2026, Orchid Pharma stock price is ₹876.15. During the trading session, the stock has moved between an intraday low of ₹857.05 and an intraday high of ₹905.00. Over the last 52 weeks, Orchid Pharma has traded between ₹480.00 and ₹1143.50.
The stock has recorded a trading volume of 65,661 shares,. Its Average Traded Price (ATP) is ₹884.40, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹876.15.
Orchid Pharma has an upper circuit limit of ₹1029.35 and a lower circuit limit of ₹686.25. The total value traded stands at ₹5.81 CR, and the delivery percentage for the day is 55.8%.
The stock is currently traded with a market lot size of 1. Orchid Pharma also offers a dividend yield of 0%.
Orchid Pharma Share Price Chart
Orchid Pharma Share Key Metrics
Volume
65661.00
Market Cap
5136.95 CR
LTQ@LTP
3@876.15
ATP
884.4
Var Margin
22.51 %
Circuit Range
686.25-1029.35
Delivery %
55.8 %
Value
5.81 CR
ASM/GSM
No
Market Lot
1
Orchid Pharma Fundamentals
P/E Ratio
600.13
P/B Ratio
3.32
Div. Yield
0
Sector P/E
41.06
Sector P/B
3.86
Sec. Div. Yield
0.53
Orchid Pharma Resistance and Support
Pivot 864.27
Resistance
First Resistance
873.44
Second Resistance
889.07
Third Resistance
898.24
Support
First Support
848.64
Second Support
839.47
Third Support
823.84
Orchid Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 863.4 | 876.15 | 2.14% | 905 | 857.05 |
| Thu Nov 12 2026 | 876.45 | 857.79 | -1.03% | 879.9 | 855.09 |
| Wed Nov 11 2026 | 901.95 | 866.7 | -1.96% | 901.95 | 861 |
Orchid Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-14 | Quarterly Results |
| 2026-10-20 | Proposal for raising of funds |
| 2026-08-14 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| 2026-08-01 | Allotment of Equity Shares |
Orchid Pharma News
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On November 14, 2026
Orchid Pharma board to meet on 14 November 2026 for financial results. The meeting will review the performance for the quarter ended 30 September 2026.
Nov 11 2026 17:30:04
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Orchid Pharma has signed a licensing and supply agreement with Laboratorio Libra S.A. to introduce Exblifep in nine Latin American markets. The partnership is projected to generate a USD 80 million commercial opportunity over 10 years, with Orchid supplying the finished dosage forms.
Oct 24 2026 17:03:42
Read More
Orchid Pharma Management
| Name | Position |
|---|---|
| Ram Gopal Agarwal | Chairman |
| Manish Dhanuka | Managing Director |
Orchid Pharma Similar Stocks
Nephrocare Health Services Ltd.
624.40
1.75 (0.28%)
Innova Captab Ltd.
1161.30
-1.50 (0.13%)
IOL Chemicals And Pharmaceuticals Ltd.
200.64
-4.44 (2.17%)
Senores Pharmaceuticals Ltd.
1168.30
-48.70 (4.00%)
Morepen Laboratories Ltd.
99.64
4.74 (4.99%)
Supriya Lifescience Ltd.
634.05
-8.00 (1.25%)
Sahajanand Medical Technologies Ltd.
525.30
20.65 (4.09%)
Artemis Medicare Services Ltd.
322.35
5.60 (1.77%)
Gujarat Themis Biosyn Ltd.
388.90
1.35 (0.35%)
Orchid Pharma FAQs
The Buying Price of Orchid Pharma share is 876.15 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Orchid Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Orchid Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Orchid Pharma shares is 600.13. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Orchid Pharma shares is 3.32. Useful to assess the stock's value relative to its book value.
To assess Orchid Pharma’s valuation compare Sector P/E, P/B which are 41.06 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Orchid Pharma is 5136.95 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Orchid Pharma share price is 1143.50 & 480.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Orchid Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ORCHPHARMA
Or Download Choice FinX App
Invest in ORCHPHARMA
